These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1417673)

  • 1. Impairment of spontaneous alternation performance by an NMDA antagonist: attenuation with non-NMDA treatments.
    Walker DL; Gold PE
    Behav Neural Biol; 1992 Jul; 58(1):69-71. PubMed ID: 1417673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory.
    Walker DL; Gold PE
    Brain Res; 1991 May; 549(2):213-21. PubMed ID: 1832074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
    Parada-Turska J; Turski WA
    Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.
    Jóźwiak L; Łukawski K; Czuczwar SJ; Sieklucka-Dziuba M
    Pol J Pharmacol; 2004; 56(1):59-66. PubMed ID: 15047978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose does not reverse impairments on spontaneous alternation induced by the noncompetitive NMDA antagonist MK-801.
    Lennartz RC; Gold PE
    Neurobiol Learn Mem; 1995 Jan; 63(1):107-110. PubMed ID: 7663876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of amino acids, opioids, nitric oxide, and NMDA receptors in learning and memory consolidation in crickets.
    Jaffe K; Blanco ME
    Pharmacol Biochem Behav; 1994 Mar; 47(3):493-6. PubMed ID: 7911576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor antagonists antagonize the facilitatory effects of post-training intra-basolateral amygdala NMDA and physostigmine on passive avoidance learning.
    Jafari-Sabet M
    Eur J Pharmacol; 2006 Jan; 529(1-3):122-8. PubMed ID: 16337625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H
    Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor blockers prevents the facilitatory effects of post-training intra-dorsal hippocampal NMDA and physostigmine on memory retention of passive avoidance learning in rats.
    Jafari-Sabet M
    Behav Brain Res; 2006 Apr; 169(1):120-7. PubMed ID: 16443290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing hypotheses of spatial learning: the role of NMDA receptors and NMDA-mediated long-term potentiation.
    Cain DP; Saucier D; Boon F
    Behav Brain Res; 1997 Mar; 84(1-2):179-93. PubMed ID: 9079784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks.
    Spangler EL; Bresnahan EL; Garofalo P; Muth NJ; Heller B; Ingram DK
    Pharmacol Biochem Behav; 1991 Dec; 40(4):949-58. PubMed ID: 1667826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks.
    Bischoff C; Tiedtke PI
    Eur J Pharmacol; 1992 Mar; 213(2):269-73. PubMed ID: 1355738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade.
    Roesler R; Vianna MR; de-Paris F; Quevedo J
    Neurobiol Learn Mem; 1999 Nov; 72(3):252-8. PubMed ID: 10536102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
    French ED; Ferkany J; Abreu M; Levenson S
    Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus basalis injections of N-methyl-D-aspartate enhance memory of rats in the double Y-maze.
    Mason KI; Mallet PE; Jhamandas K; Boegman RJ; Beninger RJ
    Brain Res Bull; 1999 Jan; 48(1):65-71. PubMed ID: 10210169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.
    Bardgett ME; Points M; Ramsey-Faulkner C; Topmiller J; Roflow J; McDaniel T; Lamontagne T; Griffith MS
    Neuropsychopharmacology; 2008 Jul; 33(8):1980-91. PubMed ID: 17882233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep deficits in rats after NMDA receptor blockade.
    Stone WS; Walker DL; Gold PE
    Physiol Behav; 1992 Sep; 52(3):609-12. PubMed ID: 1409928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
    Hiramatsu M; Inoue K
    Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.